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Introduction
============

Every year, approximately 900 000 adults worldwide experience major cardiac complications after surgery,[@ref1] which are associated with increased mortality[@ref2] and hospital stay.[@ref3] Preoperative non-invasive cardiac stress testing may help prevent these complications. This strategy detects underlying ischaemic heart disease and identifies individuals who might benefit from preoperative interventions, aggressive intraoperative haemodynamic management, closer postoperative surveillance, or avoiding surgery. Additionally, the results of stress testing can guide the use of perioperative β blockade, which has greatest benefit in patients with inducible ischaemia.[@ref4] Given these benefits, the American College of Cardiology and American Heart Association guidelines recommend preoperative non-invasive stress testing,[@ref5] but only in individuals with clinical risk factors for cardiac complications.

Conversely, some authors have discouraged the use of preoperative stress testing[@ref6] [@ref7] [@ref8] because it may delay surgery and has not been shown to improve postoperative outcomes. Instead, they advocate routine perioperative β blockade.[@ref6] [@ref8] This recommendation was supported by the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo II (DECREASE II) randomised trial, which evaluated routine stress testing in intermediate risk patients receiving perioperative β blockade.[@ref8] The study found no significant effect of preoperative stress testing on cardiac complications. None the less, the estimated effect had a wide 95% confidence interval (odds ratio 0.28 to 2.91) that did not exclude either substantial benefit or harm. Additionally, the Perioperative Ischemic Evaluation (POISE) trial has raised concerns about the safety of perioperative β blockade.[@ref9]

Given the potential benefits of preoperative stress testing but the lack of proved impact on outcomes, we undertook a population based cohort study of non-invasive cardiac stress testing in Ontario, Canada. Our objective was to determine whether stress testing before major elective non-cardiac surgery was associated with improved one year survival and reduced hospital stay.

Methods
=======

We used linked population based administrative healthcare databases in Ontario, Canada, to undertake a retrospective cohort study. The databases used were the Canadian Institute for Health Information (CIHI) discharge abstract database, which describes all hospital admissions; the Ontario Health Insurance Plan (OHIP) database, which describes physician billing for inpatient and outpatient services; the Registered Persons Database (RPDB), which describes demographics and vital statistics; the Corporate Providers Database (CPDB), which describes physicians' specialties; the Ontario Drug Benefit (ODB) database, which describes prescription medications dispensed to all individuals aged older than 65 years; and the 2001 Canadian census. Although these databases lack information on physiological and laboratory measures (for example, blood pressure and haemoglobin concentration), they have been validated for many other outcomes, exposures, and comorbidities.[@ref10] [@ref11] [@ref12] [@ref13] [@ref14] [@ref15] During the study period, Ontario was Canada's most populous province, with approximately 12 million residents who have access to physician and hospital services through a universal healthcare programme.

Cohort
------

Using previously described methods,[@ref16] we retrospectively identified all Ontario residents aged 40 years or older who underwent one of the following specific types of elective surgery during fiscal years 1994 to 2003 (1 April 1994 to 31 March 2004): abdominal aortic aneurysm repair; carotid endarterectomy; peripheral vascular bypass; total hip replacement; total knee replacement; large bowel surgery; liver resection; Whipple procedure; pneumonectomy; pulmonary lobectomy; gastrectomy; oesophagectomy; nephrectomy; or cystectomy. These procedures were selected because they are intermediate to high risk for perioperative cardiac complications,[@ref5] applicable to either sex, and described in research studies that used the CIHI database[@ref17] [@ref18] [@ref19] [@ref20] [@ref21]: procedure codes in the CIHI database have excellent accuracy.[@ref15]

The principal exposure was preoperative non-invasive stress testing, as defined by a physician billing for an outpatient stress test within 180 days before surgery. These tests included graded exercise treadmill testing, nuclear perfusion imaging (exercise or dipyridamole myocardial perfusion imaging using sestamibi or thallium as a radiotracer, with or without single photon emission computed tomography), and stress (exercise or dobutamine) echocardiography. We used OHIP fee codes and methods adapted from previous research.[@ref22] The 180 day window was chosen so that instances where stress testing led to preoperative coronary revascularisation could be included---it accounted for a 90 day period between stress testing and revascularisation[@ref23] and another 90 day window between revascularisation and surgery.[@ref5]

The outcomes of interest were mortality (one year after surgery) and hospital stay. Mortality was determined using the CIHI database (in hospital deaths) and the RPDB (out of hospital deaths). We used the CIHI database to measure hospital stay.

Demographic information was obtained from the RPDB. We used validated administrative data algorithms to identify cases of diabetes and hypertension.[@ref11] [@ref14] The OHIP database was used to identify any patient who required dialysis before the index surgery. We used previously described methods to identify in the CIHI database the following other comorbidities from hospital admissions within two years preceding surgery on the basis of International Classification of Diseases codes (9th revision, clinical modification; or 10th revision): ischaemic heart disease; congestive heart failure; cerebrovascular disease; pulmonary disease; chronic renal insufficiency; malignancy; liver disease; and dementia.[@ref24] [@ref25] When identifying comorbidities, only information from acute care hospital admissions before the index surgery was used to determine the presence of ischaemic heart disease, congestive heart failure, cerebrovascular disease, pulmonary disease, renal insufficiency, and liver disease. Our primary aim was to ensure that postoperative complications were not misclassified as pre-existing comorbid diseases.[@ref26] This approach also ensured that the relevant comorbidity information was almost certainly derived from data available before the preoperative cardiac stress test.

The OHIP database and the CPDB were used to identify outpatient consultations (anaesthesiology, internal medicine, and cardiology) within 60 days before surgery, echocardiography within 180 days before surgery,[@ref22] epidural anaesthesia or analgesia (hereafter referred to as anaesthesia), and intraoperative invasive monitoring. Procedure codes in the OHIP database are very accurate.[@ref15] We imputed patients' incomes on the basis of their neighbourhood median income in the 2001 Canadian census.

To understand how non-invasive stress testing might influence outcomes, we used the OHIP database to identify related processes of care before surgery---namely echocardiography, coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery---as well as processes of care after surgery---namely admission to a monitored bed (critical care unit or step-down unit) and mechanical ventilation. Additionally, the ODB database was used to identify outpatient prescriptions for β blockers or statins within 100 days before surgery. We defined new users of these medications as those who had prescriptions within 100 days before surgery but no prescriptions during the period from 180 days to one year before surgery.

Analyses
--------

A two tailed P value of less than 0.05 was used to define statistical significance, and all estimates were calculated with 95% confidence intervals. Bivariate tests were initially used to compare the characteristics of patients who did or did not undergo preoperative stress testing (*t* test, Mann-Whitney U test, χ^2^ test, Fisher's exact test).

We used propensity score methods to adjust for systematic differences in measured baseline characteristics between the two groups of patients in the study.[@ref27] [@ref28] A non-parsimonious multivariable logistic regression model was developed to estimate a propensity score for preoperative stress testing. Clinical significance guided the initial choice of covariates: age; sex; year of surgery; surgery; income; hospital type (teaching, low volume non-teaching, moderate volume non-teaching, or high volume non-teaching); comorbid disease; specialist consultations (anaesthesiology, general internal medicine, or cardiology); preoperative echocardiography; epidural anaesthesia; and intraoperative invasive monitoring. Previously described methods were used to categorise non-teaching hospitals into tertiles.[@ref29] We considered the following comorbid conditions that were present in at least 1% of the cohort: ischaemic heart disease; congestive heart failure; cerebrovascular disease; hypertension; diabetes; pulmonary disease; renal disease; and malignancy.

We then used a structured iterative approach to refine this model, with the goal of achieving a balance of covariates in the matched pairs.[@ref30] [@ref31] Covariate balance was measured using the standardised difference, where an absolute standardised difference above 10% is suggested to represent meaningful imbalance.[@ref31] [@ref32] We then matched patients who underwent testing to those who did not on the basis of a calliper width of 0.2 standard deviations of the log odds of the propensity score. This method involved sampling without replacement and has been shown to remove 98% of bias from measured covariates.[@ref33] Within the matched pairs, we used a stratified Cox proportional hazards model to compare one year survival.[@ref31] Given that the interaction term between the exposure (stress testing) and time was not statistically significant, we were satisfied that the model met the proportional hazards assumption. Other continuous and dichotomous outcomes were compared using statistical methods appropriate for paired data.[@ref31]

Subgroup analyses were performed on the basis of ischaemic heart disease, surgical procedure (vascular, orthopaedic, intraperitoneal, or intrathoracic), and Revised Cardiac Risk Index (RCRI) class (0 points, 1-2 points, or 3 or more points).[@ref34] The RCRI is composed of six equally weighted clinical risk factors: ischaemic heart disease; congestive heart failure; cerebrovascular disease; diabetes; renal insufficiency; and high risk surgery (intra-abdominal, intrathoracic, or suprainguinal vascular procedures). For the subgroup analyses, we repeated the same propensity score matching process while simultaneously forcing an exact match on the subgroup characteristics. One year survival was then compared within the subgroup specific matched pairs. We used an interaction term in the Cox model to test for any subgroup effects.[@ref35] An additional subgroup analysis was performed among patients older than 66 years to describe preoperative β blocker and statin use. We used this particular subgroup because data on outpatient prescriptions are available only for individuals aged above 65 years in Ontario.

We conducted several sensitivity analyses to test the robustness of our results. Firstly, we assessed the influence of an alternative matching method on our results. The original propensity score was modified to include an estimate of unmeasured disease burden: the number of acute care hospital admissions within two years before surgery. Secondly, we used the CIHI database to determine the association of preoperative testing with an outcome where no differences would be expected, namely surgical site infections. Previous research suggests that administrative data can identify surgical site infections with reasonable accuracy.[@ref36] The purpose of this "tracer" analysis was to assess for unmeasured residual confounding. Given that surgical site infections are associated with increased patient risk[@ref37] but should be unaffected by stress testing, we hypothesised that testing would not be associated with increased rates of these complications.

Results
=======

The study cohort consisted of 271 082 patients, of whom 23 991 (8.9%) underwent non-invasive stress testing within 180 days before surgery (tables 1[](#tbl1){ref-type="table"} and 2[](#tbl2){ref-type="table"}). Some patients underwent more than one test; hence, a total of 25 877 stress tests were performed. The median time between testing and surgery was 48 days (interquartile range 16 to 101 days). A total of 7795 (30%) of these tests were ordered by cardiologists, 7234 (28%) by internists, 6281 (24%) by family physicians, 3594 (14%) by surgeons, 477 (1.8%) by anaesthesiologists, and 496 (1.9%) by other specialists. Of the patients who underwent preoperative testing, 914 (3.8%) underwent coronary angiography, 149 (0.6%) underwent percutaneous coronary intervention, and 134 (0.6%) underwent coronary artery bypass graft surgery between the dates of stress testing and surgery.

###### 

 Preoperative characteristics of entire cohort. Values are expressed as number (percentage) unless indicated otherwise

                                                Stress testing (n=23 991)   No testing (n=247 091)   P value
  --------------------------------------------- --------------------------- ------------------------ ---------
  **Demographics**                                                                                   
  Female sex                                    9662 (40.3)                 129 645 (52.5)           \<0.001
  Age (years; mean (SD))                        69.1 (9.2)                  68.3 (10.3)              \<0.001
  **Socioeconomic status**                                                                           
  Annual income (Canadian dollars; mean (SD))   24 846 (5105)               24 693 (5067)            \<0.001
  **Comorbid disease**                                                                               
  Ischaemic heart disease                       5566 (23.2)                 20 996 (8.5)             \<0.001
  Congestive heart failure                      1022 (4.3)                  6005 (2.4)               \<0.001
  Cerebrovascular disease                       1684 (7.0)                  10 206 (4.1)             \<0.001
  Hypertension                                  14 887 (62.1)               130 950 (53.0)           \<0.001
  Diabetes                                      5881 (24.5)                 43 442 (17.6)            \<0.001
  Pulmonary disease                             1582 (6.6)                  12 425 (5.0)             \<0.001
  Dialysis or renal disease                     481 (2.0)                   2907 (1.2)               \<0.001
  Malignancy                                    2265 (9.4%)                 21 647 (8.8)             0.004
  **Specialist consultation\***                                                                      
  Anaesthesiology                               12 967 (54.0)               91 749 (37.1)            \<0.001
  General internal medicine                     5758 (24.0)                 57 416 (23.2)            0.008
  Cardiology                                    5828 (24.3)                 14 709 (6.0)             \<0.001
  **Preoperative cardiac procedure†**                                                                
  Echocardiogram                                10 855 (45.2)               21 113 (8.5)             \<0.001
  Coronary angiogram                            1256 (5.2)                  1463 (0.6)               \<0.001
  Percutaneous coronary intervention            314 (1.3)                   297 (0.1)                \<0.001
  Aorto-coronary bypass surgery                 302 (1.3)                   525 (0.2)                \<0.001

\*Within 60 days before surgery.

†Within 180 days before surgery.

###### 

 Perioperative characteristics of entire cohort. Values are expressed as number (percentage) unless otherwise indicated

                                     Stress testing (n=23 991)   No testing (n=247 091)   P value
  ---------------------------------- --------------------------- ------------------------ ---------
  **Hospital type**                                                                       
  Teaching                           7759 (32.3)                 84 786 (34.3)            \<0.001
  High volume non-teaching           5951 (24.8)                 51 582 (20.9)            
  Moderate volume non-teaching       5747 (24.0)                 54 418 (22.0)            
  Low volume non-teaching            4534 (18.9)                 56 305 (22.8)            
  **Procedure**                                                                           
  Abdominal aortic aneurysm repair   2651 (11.0)                 5280 (2.1)               \<0.001
  Carotid endarterectomy             2001 (8.3)                  10 044 (4.1)             
  Peripheral vascular bypass         2579 (10.7)                 13 467 (5.5)             
  Total hip replacement              4020 (16.8)                 60 671 (24.6)            
  Total knee replacement             5694 (23.7)                 80 771 (32.7)            
  Large bowel surgery                3363 (14.0)                 50 497 (20.4)            
  Liver resection                    273 (1.1)                   1661 (0.7)               
  Whipple procedure                  76 (0.3)                    1030 (0.4)               
  Pneumonectomy or lobectomy         1560 (6.5)                  8709 (3.5)               
  Gastrectomy or oesophagectomy      623 (2.6)                   5004 (2.0)               
  Nephrectomy                        957 (4.0)                   7900 (3.2)               
  Cystectomy                         194 (0.8)                   2057 (0.8)               
  **Intraoperative care**                                                                 
  Epidural anaesthesia               7433 (31.0)                 49 593 (20.1)            \<0.001
  Arterial line                      11 160 (46.5)               70 148 (28.3)            \<0.001
  Central venous line                3288 (13.7)                 18 883 (7.6)             \<0.001
  Pulmonary artery catheter          2270 (9.5)                  6743 (2.7)               \<0.001

Patients who underwent preoperative testing and those who did not differed with regard to all measured characteristics (tables 1 and 2). Patients who underwent testing were typically men who had surgery at a high volume or moderate volume non-teaching hospital and had an increased burden of comorbid disease. They were also more likely to be evaluated by a specialist before surgery, undergo preoperative cardiac procedures, and require intraoperative care such as epidural anaesthesia or intraoperative invasive monitoring.

Of the patients who underwent stress testing, 23 060 (96%) were successfully matched to a similar patient who did not. The covariate balance between the two arms was improved considerably by propensity score matching (tables 3[](#tbl3){ref-type="table"} and 4[](#tbl4){ref-type="table"}): the mean standardised difference between the two groups decreased from 14.9% (range 0.3 to 90.9) to 0.48% (0.02 to 1.5). Of the matched patients who underwent testing, 914 (4.0%) underwent coronary angiography, 136 (0.6%) underwent percutaneous coronary intervention, and 119 (0.5%) underwent coronary artery bypass graft surgery between the dates of stress testing and surgery.

###### 

 Preoperative characteristics of the propensity matched pairs. Values are expressed as number (percentage) unless otherwise indicated

                                                Stress testing (n=23 060)   No stress testing (n=23 060)   Absolute standardised difference   
  --------------------------------------------- --------------------------- ------------------------------ ---------------------------------- --------
  **Demographics**                                                                                                                            
  Female sex                                    13 572 (58.9)               13 623 (59.1)                  24.6%                              0.4%
  Age (years; mean (SD))                        69.2 (9.2)                  69.2 (9.2)                     7.6%                               \<0.1%
  **Socioeconomic status**                                                                                                                    
  Annual income (Canadian dollars; mean (SD))   24 837 (5104)               24 810 (5155)                  3.0%                               0.5%
  **Comorbid disease**                                                                                                                        
  Ischaemic heart disease                       5272 (22.9)                 5343 (23.2)                    41.1%                              0.7%
  Congestive heart failure                      1011 (4.4)                  1018 (4.4)                     10.2%                              0.1%
  Cerebrovascular disease                       1638 (7.1)                  1661 (7.2)                     12.6%                              0.4%
  Hypertension                                  14 355 (62.3)               14 381 (62.4)                  18.4%                              0.2%
  Diabetes                                      5655 (24.5)                 5572 (24.2)                    17.1%                              0.8%
  Pulmonary disease                             1528 (6.6)                  1562 (6.8)                     6.7%                               0.6%
  Dialysis or renal disease                     463 (2.0)                   458 (2.0)                      6.6%                               0.2%
  Malignancy                                    2185 (9.5)                  2210 (9.6)                     2.4%                               0.4%
  **Specialist consultation\***                                                                                                               
  Anaesthesiology                               12 299 (53.3)               12 279 (53.2)                  34.4%                              0.2%
  General internal medicine                     5670 (24.6)                 5804 (25.2)                    1.8%                               1.3%
  Cardiology                                    5084 (22.0)                 4941 (21.4)                    53.0%                              1.5%
  **Preoperative cardiac procedure†**                                                                                                         
  Echocardiogram                                9948 (43.1)                 9909 (43.0)                    90.9%                              0.3%

\*Within 60 days before surgery.

†Within 180 days before surgery.

###### 

 Perioperative characteristics of the propensity matched pairs. Values are expressed as number (percentage) unless otherwise indicated

                                     Stress testing (n=23 060)   No stress testing (n=23 060)   Absolute standardised difference   
  ---------------------------------- --------------------------- ------------------------------ ---------------------------------- --------
  **Hospital type**                                                                                                                
  Teaching                           7647 (33.2)                 7645 (33.2)                    4.2%                               \<0.1%
  High volume non-teaching           5618 (24.4)                 5639 (24.5)                    9.4%                               0.2%
  Moderate volume non-teaching       5432 (23.6)                 5336 (23.1)                    4.6%                               0.9%
  Low volume non-teaching            4363 (18.9)                 4440 (19.3)                    9.6%                               0.8%
  **Procedure**                                                                                                                    
  Abdominal aortic aneurysm repair   2247 (9.7)                  2262 (9.8)                     36.5%                              0.2%
  Carotid endarterectomy             1954 (8.5)                  1914 (8.3)                     17.8%                              0.6%
  Peripheral vascular bypass         2384 (10.3)                 2393 (10.4)                    19.5%                              0.1%
  Total hip replacement              4011 (17.4)                 4043 (17.5)                    19.4%                              0.4%
  Total knee replacement             5632 (24.4)                 5682 (24.6)                    20.0%                              0.5%
  Large bowel surgery                3276 (14.2)                 3282 (14.2)                    17.1%                              \<0.1%
  Liver resection                    272 (1.2)                   294 (1.3)                      4.9%                               0.9%
  Whipple procedure                  68 (0.3)                    57 (0.2)                       1.7%                               0.9%
  Pneumonectomy or lobectomy         1460 (6.3)                  1431 (6.2)                     13.7%                              0.5%
  Gastrectomy or oesophagectomy      609 (2.6)                   589 (2.6)                      3.8%                               0.5%
  Nephrectomy                        917 (4.0)                   975 (4.2)                      4.3%                               1.3%
  Cystectomy                         180 (0.8)                   188 (0.8)                      0.3%                               0.4%
  **Intraoperative care**                                                                                                          
  Epidural anaesthesia               6895 (29.9)                 6842 (29.7)                    25.2%                              0.5%
  Arterial line                      10 497 (45.5)               10 577 (45.9)                  38.1%                              0.7%
  Central venous line                3000 (13.0)                 3009 (13.0)                    19.7%                              0.1%
  Pulmonary artery catheter          2037 (8.8)                  2070 (9.0)                     28.4%                              0.5%

Within the matched cohort, one year survival was higher among patients who had undergone preoperative testing than in those who had not (hazard ratio (HR) 0.92, 95% CI 0.86 to 0.99, P=0.03; fig 1[](#fig1){ref-type="fig"}). This corresponded to a number needed to treat[@ref38] to prevent mortality at one year of 221 (95% CI 111 to 16 067). In hospital mortality and hospital stay were also reduced among patients who underwent stress testing (relative risk (RR) 0.85, 95% CI 0.73 to 0.98; P=0.03 and 8.72 days *v* 8.96 days, difference −0.24 days, 95% CI −0.07 to −0.43; P\<0.001, respectively; table 5[](#tbl5){ref-type="table"}). Patients who had undergone stress testing were more likely to be admitted to a monitored bed after surgery than were those who had not undergone testing (RR 1.09, 95% CI 1.06 to 1.12; P\<0.001; table 5). Conversely, rates of postoperative mechanical ventilation were similar in the two groups (RR 1.02, 95% CI 0.98 to 1.08; P=0.25).

![**Fig 1** Survival curves for postoperative all cause mortality in patients who did (n=23 060) or did not (n=23 060) undergo preoperative stress testing (matched by propensity score) over one year after surgery](wijd678557.f1_default){#fig1}

###### 

 Processes of care and outcomes in the propensity matched pairs. Values are expressed as number (percentage) unless otherwise indicated

                                         Stress testing (n=23 060)   No stress testing (n=23 060)   Difference (95% CI)
  -------------------------------------- --------------------------- ------------------------------ ------------------------
  **Preoperative cardiac procedure\***                                                              
  Coronary angiogram                     1139 (4.9)                  549 (2.4)                      RR 2.08 (1.88 to 2.92)
  Percutaneous coronary intervention     288 (1.2)                   132 (0.6)                      RR 2.18 (1.78 to 2.68)
  Aorto-coronary bypass surgery          267 (1.2)                   213 (0.9)                      RR 1.25 (1.05 to 1.50)
  **Postoperative care†**                                                                           
  Admission to a monitored bed           6175 (26.8)                 5682 (24.6)                    RR 1.09 (1.06 to 1.12)
  Mechanical ventilation                 2672 (11.6)                 2596 (11.3)                    RR 1.02 (0.98 to 1.08)
  **Outcome**                                                                                       
  One year mortality                     1622 (7.0)                  1738 (7.5)                     HR 0.92 (0.86 to 0.99)
  In-hospital postoperative death        310 (1.3)                   366 (1.6)                      RR 0.85 (0.73 to 0.98)
  Surgical site infection                1815 (7.9)                  1807 (7.8)                     RR 1.00 (0.94 to 1.07)

Abbreviations: HR, hazard ratio; RR, relative risk.

\*Within 180 days before surgery.

†Within 5 days after surgery.

In sensitivity analyses, the association of stress testing with improved one year survival was unaffected when the number of previous acute care hospital admissions within two years before the index surgery was added to the original propensity score (HR 0.92, 95% CI 0.86 to 0.99; P=0.02). Additionally, we found no statistically significant association between stress testing and surgical site infections (RR 1.00, 95% CI 0.94 to 1.07; P=0.89; table 5).

The subgroup of individuals older than 66 years consisted of 15 475 patients who underwent stress testing and 15 475 who did not. In this subgroup, 5626 (36%) of those who underwent preoperative stress testing and 3998 (26%) of those who did not were receiving β blockers (RR 1.41, 95% CI 1.36 to 1.45; P\<0.001). Additionally, 1895 (12%) patients who had undergone testing were new β blocker users, compared with 827 (5.3%) who had not undergone testing (RR 2.23, 95% CI 2.12 to 2.48; P\<0.001). More patients in the stress testing group were receiving statins (5000 (32%)) than were those who had not been tested (3679 (24%); RR 1.36, 95% CI 1.31 to 1.41; P\<0.001). A total of 974 (6.3%) patients who had undergone testing were new statin users, compared with 539 (3.5%) of patients who had not (RR 1.81, 95% CI 1.63 to 2.00; P\<0.001).

The association of stress testing with mortality was unchanged when the analyses were repeated in subgroups defined by procedure type (P=0.28 for interaction; fig 2[](#fig2){ref-type="fig"}). Conversely, the effects of testing on mortality varied with RCRI class (P=0.005) and, to a degree, ischaemic heart disease (P=0.08). Preoperative stress testing was associated with harm in low risk patients (RCRI 0 points: HR 1.35, 95% CI 1.05 to 1.74); however, it was associated with improved survival in intermediate risk patients (RCRI 1-2 points: HR 0.92, 95% CI 0.85 to 0.99) and high risk patients (RCRI 3-6 points: HR 0.80, 95% CI 0.67 to 0.97; fig 2). These differences corresponded to a number needed to treat to prevent mortality at one year of 156 for intermediate risk patients (95% CI 79 to 6127) and 38 for high risk patients (95% CI 21 to 315). Conversely, the number needed to harm in low risk patients was 179 (95% CI 97 to 1090). The relative rates of intervention use (that is, preoperative medications and cardiac procedures) were higher in low risk patients who underwent stress testing than in intermediate or high risk patients who were tested (web table A). The characteristics of the subgroups defined by RCRI class are presented in web table B.

![**Fig 2** Association of preoperative stress testing with one year survival in the subgroup analyses. The dashed vertical line represents the overall treatment effect (hazard ratio 0.92) and the solid vertical line represents a null effect (hazard ratio 1)](wijd678557.f2_default){#fig2}

Discussion
==========

In this population based retrospective cohort study, non-invasive cardiac stress testing before elective intermediate to high risk non-cardiac surgery was associated with improved one year survival and reduced hospital stay. These benefits largely applied to patients who were at high risk for cardiac complications on the basis of three or more clinical risk factors. In contrast, stress testing was associated with only minor benefits for intermediate risk patients (1-2 risk factors) and with harm in low risk individuals.

Our results suggest that preoperative stress testing should be reserved for patients with clinical risk factors for cardiac complications. In high risk patients with three or more clinical risk factors, the use of preoperative stress testing was supported by an associated moderate improvement in one year survival and favourable number needed to treat. Conversely, in intermediate risk patients with one or two clinical risk factors, testing was associated with a small, albeit statistically significant, benefit. Given the small magnitude of this effect and the associated relatively large number needed to treat, routine preoperative stress testing is not justified in intermediate risk patients. Our results do, however, support the safety and potential benefits of selective testing in intermediate risk patients. Future research should therefore determine whether stress testing provides additional prognostic information in specific subgroups of intermediate risk patients; for example, in subgroups defined by risk factors that were not captured by administrative data ( such as poor functional status) or were suggested by our subgroup analyses (such as previous history of ischaemic heart disease). Our study does not support the use of preoperative stress testing in low risk patients; furthermore, the results suggest that such testing is associated with harm.

Our results are largely consistent with the position of the American College of Cardiology and American Heart Association guidelines, which emphasise stress testing specifically in individuals who are undergoing intermediate to high risk surgery and have one or more clinical risk factors (for example, ischaemic heart disease, congestive heart failure, cerebrovascular disease, diabetes, or renal insufficiency).[@ref5] These guidelines also suggest, however, that testing be restricted to individuals who concurrently have poor or unknown functional capacity. As described above, our data sources did not capture information on exercise tolerance; consequently, further research is needed to determine whether the prognostic significance of preoperative stress testing in intermediate to high risk surgical patients varies with their functional capacity.

The beneficial effects of stress testing on mortality risk in intermediate to high risk patients are likely to be the result of a reduction in perioperative cardiac complications. Prevention of such complications would be expected to improve both length of hospital stay[@ref3] and one year survival.[@ref2] By comparison, testing was not associated with any difference in the risk of surgical site infections.

Several plausible mechanisms might, in combination, explain a reduction in cardiac complications among individuals who underwent stress testing. Firstly, the results of preoperative stress testing can help guide perioperative drug therapy with β blockers or statins. β blockade across a broad spectrum of surgical patients may cause harm,[@ref9] but it has been associated with strong benefits in patients with multiple clinical risk factors,[@ref39] especially in those with inducible ischaemia.[@ref4] Thus, preoperative stress testing may help identify subgroups of patients that would benefit from β blocker therapy. Similarly, evidence of ischaemic heart disease on preoperative testing may indicate that a patient requires statin therapy, which is also associated with improved postoperative outcomes.[@ref40]

Secondly, clinicians could use preoperative testing to determine which patients warrant closer postoperative surveillance. This hypothesis is supported by the higher rate of postoperative admission to monitored beds among patients who had undergone stress testing before surgery. Thirdly, stress testing can identify patients with high risk ischaemic heart disease who meet usual indications for revascularisation[@ref5] or who would benefit from avoiding surgery. Finally, clinicians might use the results of preoperative testing to determine which patients require more aggressive clinical care, such as stringent haemodynamic management.

In contrast to these benefits for intermediate to high risk patients, we found that stress testing was associated with harm in low risk patients. The increased mortality observed might be explained by the use of unnecessary, and potentially deleterious, interventions such as β blockade.[@ref9] [@ref39] It is noteworthy that the frequency of new β blocker use in low risk patients was 2.8 times higher in those who were tested than in those who were not (web table A).

Comparison with other studies
-----------------------------

Our study warrants comparison with the DECREASE II trial,[@ref8] in which 770 patients with one or two clinical risk factors were randomly allocated to either stress testing or no testing before major vascular surgery. Although the rates of cardiac death or myocardial infarction at 30 days after surgery did not significantly differ between the two strategies, the few outcome events (n=16) and wide 95% confidence interval (odds ratio 0.28 to 2.91) suggest that the trial was underpowered to detect a plausible treatment effect. Indeed, this confidence interval is still consistent with our finding of a small benefit for intermediate risk patients.

Additionally, the design of the DECREASE II trial might have minimised its ability to detect differences between the study arms. All participants received perioperative β blockade and similar postoperative surveillance, thereby diminishing the influence of testing on clinical care. Stress testing altered subsequent management only in that patients with extensive ischaemia were considered for preoperative revascularisation, which has not been shown to improve outcomes.[@ref41] [@ref42]

Strengths and limitations of study
----------------------------------

Our study has several strengths. Previous studies evaluated the diagnostic accuracy of preoperative stress testing,[@ref43] [@ref44] whereas our study focused on the clinically relevant question of whether it influences outcomes. Additionally, the large sample size enabled us to detect small treatment effects that would have been deemed non-significant in smaller studies. The population based sample we used describes the effects of preoperative stress testing in "real world" clinical care, as opposed to in a protocol driven randomised trial. Thus, our findings can be generalised to other healthcare systems reasonably similar to that in Ontario, Canada. Finally, our study included only patients scheduled for elective intermediate to high risk surgery. Urgent or emergency procedures are unlikely to be delayed to facilitate preoperative stress testing, whereas patients undergoing low risk ambulatory surgery have a very low risk of major complications[@ref45] and are unlikely to benefit from preoperative stress testing. Our study, therefore, focused on individuals who had reasonable opportunities to undergo, and potentially benefit from, preoperative stress testing.

Our study also has several limitations. Firstly, we could not compare outcomes from different stress tests (for example, exercise treadmill testing and nuclear perfusion). The American College of Cardiology and American Heart Association guidelines recommend exercise electrocardiography testing as the test of choice, with the use of other modalities on the basis of factors such as resting electrocardiogram abnormalities, patient physique or build, and function tolerance.[@ref5] Given that these factors are not recorded in administrative databases, yet might be prognostically important, comparison on the basis of testing modality would be biased by residual confounding.

Secondly, our study was observational in design; hence, our results demonstrate an association between preoperative testing and survival, but do not prove causation. None the less, randomised trials of preoperative stress testing also have limitations. A trial of stress testing in intermediate risk patients would probably not be feasible. On the basis of the one year mortality rate of approximately 8.9% among intermediate risk patients in our study, roughly 31 100 participants would be required to detect a 10% relative risk reduction in a randomised trial (two tailed α of 0.05 and 80% power). Conversely, a randomised trial in high risk participants would also be large, but potentially feasible. On the basis of the 15.5% one year mortality rate among high risk participants in our study, approximately 4000 high risk individuals would be required to detect a 20% relative risk reduction (two tailed α of 0.05 and 80% power).

Thirdly, our data sources could not account for individuals who underwent preoperative coronary revascularisation on the basis of high risk findings on preoperative stress testing but subsequently died before their planned non-cardiac surgeries. These deaths before surgery are unlikely to affect our results significantly. In the stress testing arm of the cohort matched by propensity scores, 335 (1.1%) individuals subsequently underwent either percutaneous coronary intervention or coronary artery bypass graft surgery before the planned non-cardiac procedures. If the mortality rate associated with preoperative coronary revascularisation is assumed to be 2%,[@ref41] [@ref42] [@ref46] seven individuals may have undergone stress testing and revascularisation but died before their planned non-cardiac surgeries. These individuals would have been missing from our matched cohort, which included only patients who actually underwent non-cardiac surgery. None the less, even if these seven missing deaths were included in our analyses, the proportion of patients dead at one year in the stress testing arm of the matched cohort would have changed only from 7.03% to 7.06%. The corresponding difference in absolute risk between the stress testing and no testing arms would also have changed negligibly, from 0.50% to 0.47%.

Finally, the administrative healthcare databases used as data sources in our study have inherent limitations. The data in such databases do not adequately capture many postoperative complications,[@ref47] causes of death, detailed clinical information, and some processes of care (for example, inpatient medications). Such information may have helped to better describe how testing might alter outcomes. Future research on preoperative stress testing should therefore include more detailed measurements of such variables (for example, stress test results and in-hospital medications). Additionally, these administrative data were not originally collected for research purposes and may therefore be susceptible to random miscoding. However, the data are very accurate with respect to describing patient demographics,[@ref15] hospital stay,[@ref12] [@ref15] mortality,[@ref12] [@ref15] procedures,[@ref12] [@ref15] and physician services.[@ref48] Given that information on medical comorbidities can be of variable accuracy, we used definitions with generally high specificity and moderate to good sensitivity.[@ref10] [@ref11] [@ref12] [@ref14] We further improved the sensitivity of the information by using hospital admissions information from the two years preceding surgery.[@ref13] Despite these limitations, administrative data also offer important advantages of very large sample sizes, systematic data collection, and population based information free from referral bias.[@ref48]

Conclusions
-----------

Non-invasive cardiac stress testing before elective intermediate to high risk non-cardiac surgery is associated with improved one year survival and reduced hospital stay. These benefits principally apply to patients at high risk for cardiac complications on the basis of clinical risk factors. Our results are generally supportive of the current American College of Cardiology and American Heart Association guidelines for preoperative cardiac evaluation.

### What is already known on this topic

1.  Non-invasive cardiac stress testing can help risk stratify surgical patients for perioperative cardiac complications and thereby better inform clinical care

2.  Current consensus based guidelines recommend non-invasive stress testing before surgery, but only in individuals with clinical risk factors for cardiac complications

3.  The effect of preoperative stress testing on postoperative clinical outcomes is unclear

### What this study adds

1.  Preoperative stress testing was associated with reduced one year mortality, hospital stay, and hospital mortality

2.  These benefits largely applied to patients who were at high risk for cardiac complications on the basis of three or more clinical risk factors

3.  In contrast, stress testing was associated with only minor benefits for intermediate risk patients (one or two risk factors) and with harm in low risk individuals
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